BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

Current stock price

15.81 USD
+0.48 (+3.13%)
At close:
15.81 USD
0 (0%)
After Hours:

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • BWAY had positive earnings in the past year.
  • In the past year BWAY had a positive cash flow from operations.
  • In the past 5 years BWAY reported 4 times negative net income.
  • In multiple years BWAY reported negative operating cash flow during the last 5 years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • With an excellent Return On Assets value of 5.53%, BWAY belongs to the best of the industry, outperforming 80.85% of the companies in the same industry.
  • BWAY has a better Return On Equity (8.92%) than 80.32% of its industry peers.
  • BWAY has a Return On Invested Capital of 2.75%. This is in the better half of the industry: BWAY outperforms 70.74% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BWAY's Profit Margin of 12.73% is amongst the best of the industry. BWAY outperforms 86.17% of its industry peers.
  • With a decent Operating Margin value of 5.78%, BWAY is doing good in the industry, outperforming 71.81% of the companies in the same industry.
  • BWAY has a better Gross Margin (74.92%) than 84.57% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. BWAY Health Analysis

2.1 Basic Checks

  • BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for BWAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 8.60 indicates that BWAY is not in any danger for bankruptcy at the moment.
  • BWAY has a better Altman-Z score (8.60) than 84.57% of its industry peers.
  • BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • BWAY has a Debt to FCF ratio of 0.37. This is amongst the best in the industry. BWAY outperforms 92.02% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.08, BWAY is doing good in the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 8.6
ROIC/WACC0.32
WACC8.51%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.19, BWAY is in line with its industry, outperforming 55.85% of the companies in the same industry.
  • A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
  • BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 63.83% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. BWAY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 117.91% over the past year.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%

3.2 Future

  • BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.62% yearly.
  • The Revenue is expected to grow by 23.69% on average over the next years. This is a very strong growth
EPS Next Y25.19%
EPS Next 2Y39.53%
EPS Next 3Y35.62%
EPS Next 5YN/A
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A

3.3 Evolution

BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1 1.5

5

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.10, the valuation of BWAY can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 75.00% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of BWAY to the average of the S&P500 Index (27.87), we can say BWAY is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 20.02, BWAY is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 80.85% of the companies in the same industry.
  • BWAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.51.
Industry RankSector Rank
PE 25.1
Fwd PE 20.02
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 64.89% of the companies listed in the same industry.
  • 76.60% of the companies in the same industry are more expensive than BWAY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.51
EV/EBITDA 115.77
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BWAY's earnings are expected to grow with 35.62% in the coming years.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y39.53%
EPS Next 3Y35.62%

0

5. BWAY Dividend Analysis

5.1 Amount

  • BWAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (4/17/2026, 8:00:02 PM)

After market: 15.81 0 (0%)

15.81

+0.48 (+3.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners5.26%
Inst Owner Change0.04%
Ins Owners15.17%
Ins Owner Change0%
Market Cap632.92M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price Target0.05 (-99.68%)
Short Float %N/A
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)-59.44%
PT rev (3m)-59.64%
EPS NQ rev (1m)-51.02%
EPS NQ rev (3m)-51.14%
EPS NY rev (1m)-51.02%
EPS NY rev (3m)-48.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE 25.1
Fwd PE 20.02
P/S 12.89
P/FCF 34.51
P/OCF 28.42
P/B 9.03
P/tB 9.03
EV/EBITDA 115.77
EPS(TTM)0.63
EY3.98%
EPS(NY)0.79
Fwd EY4.99%
FCF(TTM)0.46
FCFY2.9%
OCF(TTM)0.56
OCFY3.52%
SpS1.23
BVpS1.75
TBVpS1.75
PEG (NY)1
PEG (5Y)N/A
Graham Number4.98084 (-68.5%)
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 8.6
F-Score5
WACC8.51%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y25.19%
EPS Next 2Y39.53%
EPS Next 3Y35.62%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5Y44.57%
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 5 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Fairly Valued.


Can you provide the profitability details for BRAINSWAY LTD-ADR?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


How financially healthy is BRAINSWAY LTD-ADR?

The financial health rating of BRAINSWAY LTD-ADR (BWAY) is 7 / 10.